1

Hi,
Greetings. This is to let you know that we provide 100 % plagiarism free
content. However, if it is showing plagiarism, please share the report with us so that
we may address your concerns.
Regards.

Pathophysiology, Mechanism and Treatment of Anemia

[Name]
[Instructor]
[Course]
[University]
[Date]

Abstract
An extensive literature review was conducted in order to thoroughly study the conditions related
to the anemia. The overall pathophysiology of the disease is discussed in detail. Anemia is of
many types that is either short term or mild. However the main cause of anemia identified is lack
of red blood cells, blood loss and high rate of red blood cell destruction. As red blood cells are
mainly responsible for the carrying of oxygen to different part of the body thus any problem
relating RBCs usually result in affecting every body activity and especially metabolism. People
suffering from anemia basically feel tired and are unable to peform any vigorous physical
activity. Long-lasting anemia is very lethal as it can result in damage of vital body organs such as
brain, heart and kidneys. Severe anemic cases may also lead to the death of the patient. Different
types of anemia having specific causes and traits are identified. Treatments also differ depending
on the type of anemia and also vary with respect to the age, health and extent of disease.
Temporay treatment that is common for various anemic patients include blood transfusion,
antibiotics, vitamins and mineral supplements. However, permanent treatments include blood
and marrow stem cell transplant and sugery. New therapies are still under consideration in the
ongoing research studies. Many disorders commonly cancers may also lead to anemia mainly in
the older age. Anemia caused by vitamin B12 deficiency is commonly mistaken for dementia in
older adults because it greatly affects the mental and nervous system. Further research and
understanding of different mechanisms contributing to anemia are still needed in order to fully
control the disease and reduce the mortality rate.

Pathophysiology, Mechanism and Treatment of Anemia

Overview:
Anemia is termed as a condition in which the blood contains lower number of red blood
cells (RBCs) and these RBCs are hemoglobin deficient. Hemoglobin is an iron rich protein that
carries oxygen and gives the blood its red color. It is vital protein that helps in transferring the
oxygen from the lungs to rest of the body (Shaw and Friedman, 2011). However, deficient
hemoglobin in the blood may result in an insufficient supply of oxygen in the tissues causing
anemia (Beutler, 2006).
Introduction:
Anemia is a condition that accounts for low number of RBCs in the blood. The body of
an anemic individual never gets enough oxygen-rich blood. Therefore, the person suffering from
this condition usually feel tired and exhausted. Blood is composed of more than four thousand
different types of components, among them the four most important components are RBCs,
white blood cells (WBCs), platelets and plasma. RCSs are the cells that carry oxygen and
distribute to all parts of the body. RCSs are also known as erythrocytes (Gordon-Smith, 2013).
The cytoplasm content of erythrocytes is rich in iron-containing molecule known as hemoglobin.
Mature RBCs are oval bioconcave flexible disks. In a normal human adult 2.4 billion RBCs are
produced every second (Branton and Keith, 1972). These cells are created in bone marrow and
then circulate throughout the body from 100-120 days and are then recycled by macrophages.
Red blood cells are created through a progression of complex and particular steps. The color of
the RBCs is mainly due to the heme group attached to them (Lanzkowsky, 2011). The

hemoglobin particle is the utilitarian unit of the red blood cells and is a complex protein structure
that is inside the red blood cells. In spite of most cells in the human body, red blood cells don't
have a core (metabolic center of a cell) (Hillman and Finch, 1996). Despite the fact that RBCs
are made inside the bone marrow, numerous different variables are included in their generation.
Case in point, iron is a vital part of the hemoglobin particle; erythropoietin, a molecule emitted
by the kidneys, advances the development of red blood cells in the bone marrow (Anstee, 2010).

By and large characterized, anemia is present when the hemoglobin fixation is underneath
an ordinary worth taking into account the reference populace. The mean ordinary estimation of
hemoglobin is reliant on age, sexual orientation, race, and elevation. As indicated by World
Health Organization criteria, secured more than 40 years back, the lower furthest reaches of
ordinary in grown-ups is 13 g/dL in men and 12 g/dL in ladies (Who.int, 2015).
Levels of hemoglobin differ according to the race, for instance African-Americans have
physiologic levels of hemoglobin and hematocrit that are lower than range 1. A drop in the
hemoglobin level is seen in more established men that may be the after effect of lessened
androgen levels. This supposition does not, on the other hand, deter the requirement for
assessment, particularly if the patient is known to have had ordinary values in the later past; the
recognition of a slight decline in the hemoglobin level is frequently a sign of hidden sickness, for
example, myelodysplastic disorder. Different highlights that ought to incite examination
incorporate microcytic or macrocytic files, hoisted reticulocyte tally (implying hemolysis), and
leukocyte or platelet anomalies (Lee et al., 2005).
Predominance

Studies have reported that 3.4 million Americans suffer from anemic condition. Roughly
20% to 30% of hospitalized patients have some level of anemia, with the most noteworthy rate
being found in escalated consideration units (Hematology.org, 2015). The most widely
recognized reasons for anemia seen as a rule practice are neoplastic, aggravation "chronic
disease," iron lack, development issue, hemolytic anemias, intense dying, and marrow damage
(Disorders of Iron Metabolism, 2000). In the elderly people 30% to 45% of anemia stays
unexplained even after careful hematologic assessment. Hypotheses of the instrument of this
hypo proliferative paleness range from low testosterone level, mysterious myelodysplastic
disorder, to deserts in oxygen sensing by erythropoietin-delivering cells. Then again, no bringing
together cause has been recognized (Nemeth et al., 2004).
Pathophysiology
Anemia can likewise be characterized physiologically by the level of debilitation of tissue
oxygenation. Oxygen supply to tissues is controlled by a very much adjusted system that relies
on upon the relative rate of oxygen supply and interest. Tissue oxygen delivery is dependent on
the hemoglobin concentration, oxygen saturation and oxygen affinity, the degree and rate of
change in blood volume, and the capacity for the cardiovascular and pulmonary systems to
compensate. These, in turn, determine the clinical manifestations of anemia, on which the
decision to transfuse should ultimately be based. Tissue oxygen delivery is also the major
controlling factor of erythropoietin through the synthesis and release of erythropoietin (EPO) by
the proximal tubular cells or per tubular interstitial cells in the kidney (Thomas et al., 2005).
EPO amalgamation is represented by the actuation of hypoxia inducible element 1 (HIF1), which controls the metabolic reactions of different quality items to hypoxia. HIF-1 ties and

initiates the hypoxia-responsive transcriptional enhancer in the EPO quality administrative

district that upregulates EPO articulation. EPO invigorates erythroid antecedent cells (CFU-E
[colony-shaping units"erythroid]), prompting expanded multiplication and shortening of their
development time. The marrow reacts to expanded EPO maximally in 4 to 7 days if enough iron
is accessible. Erythropoiesis can be expanded by as much as a component of 8. Common of an
endocrine circle criticism system, there is a backwards connection between the hemoglobin and
EPO levels measured in the blood. Despite the fact that this connection remains constant in
straightforward iron inadequacy, it is to a degree contorted in the paleness connected with
aggravation or perpetual sickness, in which there may be a blunted EPO reaction. This has made
forecast of the hemoglobin reaction to treatment with exogenous EPO flighty, aside from in
restricted circumstances. Inverse relation between degree of anemia and erythropoietin levels is
illustrated in the Figure 1 below.

Figure 1: Inverse relation between degree of anemia and erythropoietin levels

(Clevelandclinicmeded.com, 2015).

Anemia Causes
Numerous medicinal conditions cause frailty. Normal reasons for sickliness incorporate
the accompanying:

Anemia from active bleeding: Loss of blood through overwhelming menstrual draining
or wounds can bring about paleness. Gastrointestinal ulcers or tumors, for example,
disease of the colon might gradually overflow blood and can likewise bring about
sickness (Blood testing causes anemia, 2007).

Iron deficiency anemia: The bone marrow needs iron to make red blood cells. Iron (Fe)
assumes an imperative part in the best possible structure of the hemoglobin molecule.
On the off chance that iron admission is restricted or insufficient because of poor dietary
admission, pallor may happen subsequently (IOANNOU et al., 2001). This is called iron
deficiency anemia. Iron inadequacy paleness can likewise happen when there are
stomach ulcers or different wellsprings of moderate, constant dying (colon disease,
uterine malignancy, intestinal polyps, hemorrhoids, and so on). In these sorts of
situations, continuous, perpetual moderate blood misfortune, iron is additionally lost
from the body (as a part of blood) at a higher rate than ordinary and can bring about iron
deficiency anemia (Nahon et al., 2000).

Anemia of chronic disease: Any long haul therapeutic condition can prompt weakness
(Agarwal and Prchal, 2009). The careful instrument of this procedure in obscure,

however any long-standing and continuous medicinal condition, for example, a ceaseless
disease or a tumor may precipitate this kind of anemia (Means, 1995).

Anemia related to kidney disease: The kidneys release a hormone called the
erythropoietin that helps the bone marrow make red blood cells. In individuals with
ceaseless (long-standing) kidney infection (CKD or end stage renal sickness (ESRD), the
generation of this hormone is lessened and therefore the development of red blood cells
is also reduced, causing anemia.

Anemia related to pregnancy: Water weight and liquid addition amid pregnancy weakens
the blood, which may be reflected as weakness since the relative centralization of red
blood cells is lower.

Anemia related to poor nutrition: Vitamins and minerals are obliged to make red blood
cells. Notwithstanding iron, vitamin B12 and folate (or folic corrosive) are needed for
the best possible generation of hemoglobin (Hgb). Inadequacy in any of these may bring
about anemia in light of lacking generation of red blood cells. Poor dietary admission is
an essential reason for low folate and low vitamin B12 levels. Strict vegans who don't
take sufficient vitamins are at danger to create vitamin B12 inadequacy (Agusti, 2007).

Pernicious anemia: There likewise may be an issue in the stomach or the entrails
prompting poor assimilation of vitamin B12. This may prompt sickliness due to vitamin
B12 inadequacy known as malevolent pallor.

Sickle cell anemia: In a few people, the issue may be identified with generation of
anomalous hemoglobin atoms. In this condition, the hemoglobin issue is subjective, or

10

practical. Strange hemoglobin particles may bring about issues in the respectability of
the red platelet structure and they may get to be sickling formed (sickle cells). There are
diverse sorts of sickle cell iron deficiency with distinctive seriousness levels. This is
commonly genetic and is more regular in those of African, Middle Eastern, and
Mediterranean heritage. Individuals with sickle cell weakness can be diagnosed as ahead
of schedule as youth relying upon the seriousness and indications of their illness
(Stockmann and Fandrey, 2006).
Anemia Symptoms
Insufficient RBCs in the blood result in delivering less oxygen to the body tissues. The
clinical indications of anemia rely on upon the singular's capacity to make up for a misfortune in
oxygen-conveying limit. The more unexpected the onset of the anemia, the more sensational the
presentation. A sudden loss of more than 33% of a quiet's blood volume, for instance, normally
brings about hypotension, respiratory trouble, and intense mental status change, even in a
youthful, beforehand solid patient. With the more commonplace unending improvement of iron
deficiency, the clinical changes are subtler and rely on upon the quiet's age and comorbid
conditions. The most recognizable of these progressions is an increment in heart yield bringing
on manifestations of palpitations and tachycardia, windiness, particularly on effort, and
unsteadiness or tipsiness. The patient may additionally gripe of commotion in the ears. This is
not genuine tinnitus, yet rather a thundering sound created by quickened blood course through
the ear. A few patients build up an inclination of significant summed up weariness that can be
joined by a loss of mental keenness, bringing about diminished capacity to perform
straightforward errands, for example, perusing a daily paper (Price et al., 2011). These endless

11

side effects are aggravated by basic coronary corridor sickness, congestive heart disappointment,
and characteristic aspirator or cardiovascular ailment (Bloxham et al., 2011).

Anemia Medications
Medications and treatments currently employed in the patients suffering from anemia are
as follows:

Iron may be taken amid pregnancy and when iron levels are low. It is imperative to focus
the reason for iron insufficiency and treat it appropriate

Vitamin supplements may supplant folate and vitamin B12 in individuals with poor
dietary patterns. In individuals with malignant frailty why should not able assimilate
sufficient measures of vitamin B12, month to month infusions of vitamin B12 are
normally used to packed the vitamin B 12 levels and right the anemia.

Epoetin alfa (Procrit or Epogen) is a solution that can be given as an infusion to build red
platelet creation in individuals with kidney issues. The generation of erythropoietin is
diminished in individuals with cutting edge kidney ailment, as depicted prior.

Halting a pharmaceutical that may be the reason for anemia might likewise switch
anemia after counsel with a doctor.

In the event that liquor is the reason for anemia, then notwithstanding taking vitamins
and keeping up satisfactory nourishment, liquor utilization needs to be halted.

12

Future studies and conclusions:

Continuous studies, for example, RED-HF ought to have the capacity to all the more
unmistakably characterize whether there is a part for erythropoietin-stimulating agents ESAs in
the treatment of iron deficient heart disappointment patients. On the off chance that the study
results are sure, there may be a requirement for future studies looking at the relative formal of
ESAs and iron in heart disappointment patients. Given that most ESA studies were directed in
patients with systolic brokenness however a vast extent of patients have protected systolic
capacity, future studies ought to elucidate the part of ESAs in patients with safeguarded systolic
capacity.
There ought to be more investigations of anemic patients with ischemic coronary illness.
Future studies ought to better illuminate the impact of chronic kidney ailment on the viability of
different anemia medications. Instead of the high hemoglobin targets trials to date have
inspected in patients with cutting edge kidney disease, future studies may consider the
estimation of more direct hemoglobin targets given the remaining instability for patients with
moderate anemia (Agarwal and Prchal, 2009). There is a squeezing requirement for more trials
looking at the part of blood transfusions; treatment of patients with stable or compensated heart
disappointment, too as patients with steady, asymptomatic or effectively symptomatic ischemic
coronary illness, stays unverifiable.
You may have the capacity to counteract rehash scenes of a few sorts of paleness,
particularly those brought about by absence of iron or vitamins. Dietary changes or supplements
can keep these sorts of weakness from happening once more. Treating frailty's basic reason may
keep the condition (or avert rehash scenes). Case in point, if prescription is creating your

13

paleness, your specialist may endorse another sort of medication. To keep weakness from
deteriorating, enlighten your specialist regarding the majority of your signs and indications.
Chat with your specialist about the tests you may require and take after your treatment
arrangement. You can't keep a few sorts of acquired weakness, for example, sickle cell pallor.
On the off chance that you have an acquired weakness, chat with your specialist about treatment
and continuous consideration.

14

References
Shaw, J. and Friedman, J. (2011). Iron Deficiency Anemia: Focus on Infectious Diseases in
Lesser Developed Countries. Anemia, 2011, pp.1-10.
Branton, D. and Keith, A. (1972). Book Review:Structure and Function of Biological
Membranes. Lawrence I. Rothfield. The Quarterly Review of Biology, 47(4), p.447.
Gordon-Smith, T. (2013). Structure and function of red and white blood cells. Medicine, 41(4),
pp.193-199.
Anstee, D. (2010). The functional importance of blood group-active molecules in human red
blood cells. Vox Sanguinis, 100(1), pp.140-149.
Who.int, (2015). WHO | Anaemia. [online] Available at: http://www.who.int/topics/anaemia/en/
[Accessed 30 Apr. 2015].
Hematology.org,

(2015).

Anemia.

[online]

Available

at:

http://www.hematology.org/Patients/Anemia/ [Accessed 30 Apr. 2015].

Blood testing causes anemia. (2007). Dial. Transplant., 36(3), pp.162-162.
Beutler, E. (2006). The definition of anemia: what is the lower limit of normal of the blood
hemoglobin concentration?. Blood, 107(5), pp.1747-1750.
Hillman, R. and Finch, C. (1996). Red cell manual. Philadelphia: F.A. Davis.

15

Lanzkowsky, P. (2011). Manual of pediatric hematology and oncology. Amsterdam:

Elsevier/Academic Press.
Stockmann, C. and Fandrey, J. (2006). HYPOXIA-INDUCED ERYTHROPOIETIN
PRODUCTION: A PARADIGM FOR OXYGEN-REGULATED GENE EXPRESSION.
Clin Exp Pharmacol Physiol, 33(10), pp.968-979.
Disorders of Iron Metabolism. (2000). New England Journal of Medicine, 342(5), pp.364-364.
Nahon, S., Lahmek, P., Lesgourgues, B., Tuszynski, T., Manet, S., Echard, M. and Delas, N.
(2000). Evaluation of the gastrointestinal tract in patients with idiopathic iron-deficiency
anemia: Transversal study of 323 patients. Gastroenterology, 118(4), p.A1091.
IOANNOU, G., SCOTT, K., SPECTOR, J. and ROCKEY, D. (2001). Prospective evaluation of a
clinical guideline for the diagnosis and management of iron deficiency anemia.
Gastroenterology, 120(5), pp.A405-A405.
Means, R. (1995). Pathogenesis of the anemia of chronic disease: A cytokine‐mediated
anemia. Stem Cells, 13(1), pp.32-37.
Agarwal, N. and Prchal, J. (2009). Anemia of Chronic Disease (Anemia of Inflammation). Acta
Haematol, 122(2-3), pp.103-108.
Clevelandclinicmeded.com,

(2015).

[online]

Available

http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hematologyoncology/anemia/Default.htm#bib4 [Accessed 30 Apr. 2015].

at:

16

Agarwal, N. and Prchal, J. (2009). Anemia of Chronic Disease (Anemia of Inflammation). Acta
Haematol, 122(2-3), pp.103-108.
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. and Ganz, T. (2004).
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron
regulatory hormone hepcidin. Journal of Clinical Investigation, 113(9), pp.1271-1276.
Lee, P., Peng, H., Gelbart, T., Wang, L. and Beutler, E. (2005). Regulation of hepcidin
transcription by interleukin-1 and interleukin-6. Proceedings of the National Academy of
Sciences, 102(6), pp.1906-1910.
Thomas, M., Cooper, M., Tsalamandris, C., MacIsaac, R. and Jerums, G. (2005). Anemia With
Impaired Erythropoietin Response in Diabetic Patients. Archives of Internal Medicine,
165(4), p.466.
Price, E., Mehra, R., Holmes, T. and Schrier, S. (2011). Anemia in older persons: Etiology and
evaluation. Blood Cells, Molecules, and Diseases, 46(2), pp.159-165.
Agusti, A. (2007). Inflammation in COPD. Respiratory Medicine: COPD Update, 3(4), pp.119120.
Bloxham, E., Vagadia, V., Scott, K., Francis, G., Saravanan, V., Heycock, C., Rynne, M.,
Hamilton, J. and Kelly, C. (2011). Anaemia in rheumatoid arthritis: can we afford to
ignore it?. Postgraduate Medical Journal, 87(1031), pp.596-600.